Tekla Life Sciences Investors (HQL) Income Statement Analysis

See more : Virtual Ed Link, Inc. (VRED) Income Statement Analysis – Financial Results

Complete financial analysis of Tekla Life Sciences Investors (HQL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tekla Life Sciences Investors, a leading company in the Asset Management industry within the Financial Services sector.

You may be interested

Simmons First National Corporation (SFNC) Income Statement Analysis – Financial Results
Grindr Inc. WT (GRND-WT) Income Statement Analysis – Financial Results
LOG Commercial Properties e Participações S.A. (LOGG3.SA) Income Statement Analysis – Financial Results
Logistea AB (publ) (LOGI-B.ST) Income Statement Analysis – Financial Results
Angkor Resources Corp. (ANKOF) Income Statement Analysis – Financial Results

Tekla Life Sciences Investors (HQL)

Industry: Asset Management

Sector: Financial Services

Website: https://www.teklacap.com/hql.html

About Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	1998	1997	1996
Revenue	86.69M	23.52M	-103.25M	65.69M	124.08M	-69.34M	29.82M	69.81M	6.29M	1.32M	876.79K	516.76K	2.14M	570.00K	1.82M	460.00K	1.67M	2.88M	2.30M	890.00K	320.00K	610.00K	940.00K	1.77M	140.00K	320.00K	420.00K
Cost of Revenue	0.00	5.24M	5.55M	6.08M	5.21M	5.00M	4.77M	4.61M	4.95M	5.65M	4.14M	3.10M	2.48M	3.02M	2.99M	2.85M	3.76M	3.62M	2.93M	2.81M	2.78M	2.44M	2.86M	3.26M	1.64M	1.63M	1.60M
Gross Profit	86.69M	18.28M	-108.80M	59.61M	118.88M	-74.35M	25.05M	65.20M	1.34M	-4.33M	-3.26M	-2.58M	-335.50K	-2.45M	-1.17M	-2.39M	-2.09M	-740.00K	-630.00K	-1.92M	-2.46M	-1.83M	-1.92M	-1.49M	-1.50M	-1.31M	-1.18M
Gross Profit Ratio	100.00%	77.71%	105.37%	90.75%	95.80%	107.22%	84.00%	93.40%	21.34%	-327.02%	-372.18%	-499.89%	-15.64%	-429.82%	-64.29%	-519.57%	-125.15%	-25.69%	-27.39%	-215.73%	-768.75%	-300.00%	-204.26%	-84.18%	-1,071.43%	-409.38%	-280.95%
Research & Development	0.00	0.00	-3.28	1.43	3.15	-1.84	0.80	1.46	-1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	1.33M	903.14K	1.08M	844.02K	751.32K	876.76K	880.76K	991.51K	5.23M	6.04M	4.64M	3.69M	3.43M	1.15M	630.00K	590.00K	680.00K	720.00K	550.00K	510.00K	530.00K	450.00K	470.00K	340.00K	230.00K	190.00K	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	1.33M	903.14K	1.08M	844.02K	751.32K	876.76K	880.76K	991.51K	-1.89	6.04M	4.64M	3.69M	3.43M	1.15M	630.00K	590.00K	680.00K	720.00K	550.00K	510.00K	530.00K	450.00K	470.00K	340.00K	230.00K	190.00K	0.00
Other Expenses	85.35M	22.62M	275.97K	313.69K	278.66K	259.76K	466.64K	423.33K	20.74M	143.44K	130.00K	150.00K	200.00K	200.00K	160.00K	170.00K	140.00K	250.00K	160.00K	150.00K	80.00K	60.00K	120.00K	110.00K	10.00K	40.00K	290.00K
Operating Expenses	86.69M	23.52M	1.35M	1.16M	1.03M	1.14M	1.16M	1.26M	13.35M	39.18M	88.39M	84.13M	75.49M	1.35M	790.00K	760.00K	820.00K	970.00K	710.00K	660.00K	610.00K	510.00K	590.00K	450.00K	240.00K	230.00K	290.00K
Cost & Expenses	86.69M	23.52M	1.35M	1.16M	1.03M	1.14M	5.59M	5.56M	1.34M	39.18M	88.39M	84.13M	75.49M	4.37M	3.78M	3.61M	4.58M	4.59M	3.64M	3.47M	3.39M	2.95M	3.45M	3.71M	1.88M	1.86M	1.89M
Interest Income	1.04M	204.45K	50.09K	0.00	164.80K	216.70K	90.71K	90.56K		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	32.27M	72.43M		45.22M	93.03M	87.82M	78.91M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	0.00	27.60M	2.99M	4.14M	2.11M	2.88M	3.61M	3.88M	3.79M	4.72M	3.77M	3.17M	1.28M	41.27M	12.15M	-18.52M	63.17M	52.22M	-20.10M	47.35M	10.23M	40.96M	-47.89M	-93.09M	-28.63M	16.72M	23.28M
EBITDA	0.00	22.35M	-104.61M	64.54M	123.06M	-70.47M	28.67M	68.56M	0.00	0.00	0.00	0.00	78.91M	37.47M	10.19M	-21.67M	60.25M	50.51M	-21.44M	44.76M	7.16M	38.62M	-50.41M	-95.03M	-30.38M	15.19M	21.81M
EBITDA Ratio	0.00%	95.03%	101.31%	98.24%	99.17%	101.64%	204.33%	201.96%	289.30%	3,419.13%	10,610.66%	16,993.50%	3,679.80%	6,573.68%	559.89%	-4,710.87%	3,607.78%	1,753.82%	-932.17%	5,029.21%	2,237.50%	6,331.15%	-5,362.77%	-5,368.93%	-21,700.00%	4,746.88%	5,192.86%
Operating Income	0.00	-5.24M	-104.60M	64.53M	123.05M	-70.48M	-3.61M	-3.88M	-3.79M	-4.72M	-3.77M	-3.17M	-1.28M	-3.80M	-1.96M	-3.15M	-2.92M	-1.71M	-1.34M	-2.59M	-3.07M	-2.34M	-2.52M	-1.94M	-1.75M	-1.53M	-1.47M
Operating Income Ratio	0.00%	-22.29%	101.31%	98.24%	99.17%	101.64%	-12.10%	-5.56%	-60.25%	-357.04%	-429.50%	-613.43%	-59.85%	-666.67%	-107.69%	-684.78%	-174.85%	-59.38%	-58.26%	-291.01%	-959.38%	-383.61%	-268.09%	-109.60%	-1,250.00%	-478.13%	-350.00%
Total Other Income/Expenses	85.30M	27.60M	-101.61M	6.08M	5.21M	-67.60M	32.61M	72.74M	-8.12M	45.22M	93.03M	87.82M	78.91M	41.27M	12.15M	-18.52M	63.17M	52.22M	-20.10M	47.35M	10.23M	40.96M	-47.89M	-93.09M	-28.63M	16.72M	23.28M
Income Before Tax	85.30M	22.35M	-104.60M	64.53M	123.05M	-70.48M	28.66M	68.56M	-11.91M	40.50M	89.27M	84.65M	77.63M	37.47M	10.19M	-21.67M	60.25M	50.51M	-21.44M	44.76M	7.16M	38.62M	-50.41M	-95.03M	-30.38M	15.19M	21.81M
Income Before Tax Ratio	98.40%	95.02%	101.31%	98.24%	99.17%	101.64%	96.12%	98.20%	-189.33%	3,062.09%	10,181.17%	16,380.07%	3,619.95%	6,573.68%	559.89%	-4,710.87%	3,607.78%	1,753.82%	-932.17%	5,029.21%	2,237.50%	6,331.15%	-5,362.77%	-5,368.93%	-21,700.00%	4,746.88%	5,192.86%
Income Tax Expense	0.00	0.00	-2.99M	-4.15M	-2.13M	-2.88M	1.00	3.00	26.32M	45.22M	93.03M	87.82M	78.91M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	85.30M	22.35M	-104.60M	64.53M	123.05M	-70.48M	28.66M	68.56M	-11.91M	40.50M	89.27M	84.65M	77.63M	37.47M	10.19M	-21.67M	60.25M	50.51M	-21.44M	44.76M	7.16M	38.62M	-50.41M	-95.03M	-30.38M	15.19M	21.81M
Net Income Ratio	98.40%	95.02%	101.31%	98.24%	99.17%	101.64%	96.12%	98.20%	-189.30%	3,062.09%	10,181.17%	16,380.07%	3,619.95%	6,573.68%	559.89%	-4,710.87%	3,607.78%	1,753.82%	-932.17%	5,029.21%	2,237.50%	6,331.15%	-5,362.77%	-5,368.93%	-21,700.00%	4,746.88%	5,192.86%
EPS	0.00	0.79	-4.07	2.66	5.16	-3.04	1.28	3.21	1.00	2.06	4.70	5.65	5.38	2.57	0.47	-0.99	2.86	2.52	-1.11	3.55	0.59	3.38	-4.84	-10.20	-4.17	2.17	3.26
EPS Diluted	0.00	0.79	-4.07	2.66	5.16	-3.04	1.23	3.21	20.74M	2.06	4.70	5.64	5.38	2.57	0.47	-0.99	2.86	2.52	-1.11	3.55	0.59	3.38	-4.84	-10.20	-4.17	2.17	3.26
Weighted Avg Shares Out	28.06M	28.29M	25.68M	24.26M	23.85M	23.18M	22.41M	21.36M	-11.91M	19.69M	19.01M	14.99M	14.43M	14.58M	21.84M	21.95M	21.08M	20.08M	19.23M	12.61M	12.07M	11.41M	10.41M	9.32M	7.29M	7.01M	6.68M
Weighted Avg Shares Out (Dil)	28.06M	28.29M	25.68M	24.26M	23.85M	23.18M	23.30M	21.36M	-0.57	19.69M	19.01M	14.99M	14.43M	14.58M	21.84M	21.95M	21.08M	20.08M	19.23M	12.61M	12.07M	11.41M	10.41M	9.32M	7.29M	7.01M	6.68M